Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Free Cash Flow of -$18.4 million for Q1 2026, down 40.63% year-over-year from -$31.1 million in Q1 2025, and down 27.49% quarter-over-quarter from -$14.5 million in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Free Cash Flow for 10 consecutive years, with -$18.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 40.63% year-over-year to -$18.4 million; the TTM figure through Mar 2026 stood at -$65.6 million (down 3.99% YoY), while the FY2025 annual figure was -$60.3 million, down 1.77% from the prior year.
- Free Cash Flow declined to -$18.4 million in Q1 2026 per TECX's latest filing, from -$14.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$473000.0 in Q2 2023 and bottomed at -$29.1 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$16.2 million across 5 years, with a median of -$16.3 million in 2022.
- Annual changes were most pronounced in 2023 — Free Cash Flow soared 98.38% — and 2024, when it tumbled 2734.25%.
- Tectonic Therapeutic's Free Cash Flow stood at -$23.9 million in 2022, then soared by 51.32% to -$11.7 million in 2023, then plunged by 44.35% to -$16.8 million in 2024, then grew by 14.05% to -$14.5 million in 2025, then fell by 27.49% to -$18.4 million in 2026.
- Business Quant data shows TECX's Free Cash Flow at -$18.4 million in Q1 2026, -$14.5 million in Q4 2025, and -$18.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -21.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.53 Mn |
| Mar 31, 2026 | -18.44 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -16.12 Mn |
| Sep 30, 2024 | -20.19 Mn |
| Jun 30, 2024 | -12.98 Mn |
| Mar 31, 2024 | -9.25 Mn |
| Dec 31, 2023 | -11.71 Mn |
| Sep 30, 2023 | -8.49 Mn |
| Jun 30, 2023 | -473,000.00 |
| Mar 31, 2023 | -20.29 Mn |
| Dec 31, 2022 | -23.67 Mn |
| Sep 30, 2022 | -16.50 Mn |
| Jun 30, 2022 | -29.17 Mn |
| Mar 31, 2022 | -28.13 Mn |
| Dec 31, 2021 | -26.75 Mn |
| Sep 30, 2021 | -25.09 Mn |